First-in-Human Clinical Trial Marks a Breakthrough for Enginprime's OpusOne™ pVAD Enginprime Medical Inc. unveils its innovative OpusOne™ pVAD in a significant first-in-human trial, showcasing groundbreaking technology for heart failure support.

First-in-Human Clinical Trial Marks a Breakthrough for Enginprime's OpusOne™ pVAD #China #Hangzhou #pVAD #Enginprime #OpusOne

Supira Medical Raises $120M to Propel Innovative Heart Device Market Expansion Supira Medical successfully completed a $120M oversubscribed Series E financing to advance its cardiac support device technologies and clinical programs.

Supira Medical Raises $120M to Propel Innovative Heart Device Market Expansion #United_States #investors #Los_Gatos #Supira_Medical #pVAD